Drug intelligence / Profile preview

inulin + beta-glucans + arabinogalactan

Development stage
Preclinical
Lead developer
Biostile
Administration
Oral
01

Overview

Product BLMB (IP4) is an investigational liquid dietary supplement containing a combination of three soluble fibers: 700 mg of inulin, 30 mg of β-glucans, and 700 mg of arabinogalactan per daily dose. It was evaluated in a 2023 clinical study for its potential to aid in weight management and improve metabolic health in overweight and obese individuals with traits of metabolic syndrome. The study, which combined the supplement with an energy-restricted diet, found that this combination contributed to significant reductions in body weight, BMI, fat mass, and visceral fat, and improvements in lipid profiles. The mechanism of action is thought to involve increased satiety, modulation of the gut microbiome due to the prebiotic nature of its components, and alteration of nutrient absorption in the gastrointestinal tract.

Brand names
Ther-Biotic BiotaGenLiquid Micro Balance
Other names
BiotaGen Prebiotic Blendprebiotic blend with arabinogalactan, inulin and beta-glucans
02

Targets

CLEC7A (Dectin-1)

Beyond the preview

Go deeper on inulin + beta-glucans + arabinogalactan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on inulin + beta-glucans + arabinogalactan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call